Sientra

Sientra, Inc. operates as a medical aesthetics company, which engages in developing and commercializing plastic surgery implantable devices. It operates through two reportable segments: Breast Products and miraDry. The Breast Products segment focuses on sales of its breast implants, tissue expanders and scar management products under the brands Sientra, AlloX2, Dermaspan, Softspan and BIOCORNEUM. The miraDry segment focuses on sales of the miraDry System, consisting of a console and a handheld device which uses consumable single-use bioTips. The company was founded by Hani M. Zeini on August 29, 2003 and is headquartered in Santa Barbara, CA.

Earnings data Q1 2020

Earnings data Q2 2020

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q3 2024

Siena Holdings, Inc. operates as a holding American company that manages and operates an assisted care facility through its subsidiary. The private company is located in the US and has subsidiaries in the United States.

Sientra (SIEN) delivered earnings and revenue surprises of 15.56% and 40.40%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Sientra (SIEN) Reports Q2 Loss, Tops Revenue Estimates

Continued Strength in Core Breast Products Business Despite COVID-19 Headwinds

Sientra Reports Second Quarter 2020 Financial Results

SANTA BARBARA, Calif., July  29, 2020  (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, announced today the company will be participating in the upcoming virtual Canaccord 40th Annual Growth Conference. Sientra’s management team is scheduled to present on Thursday, August 13, 2020 at 4:00 p.m. EDT.

Sientra to Present at the Canaccord 40th Annual Growth Conference

SANTA BARBARA, Calif., July  27, 2020  (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a diversified medical aesthetics company, today announced that it will release financial results for the second quarter of 2020 after the close of trading on Monday, August 10, 2020. Sientra will host a conference call to discuss financial results the same day at 4:30 p.m. Eastern Time.

Sientra to Report Second Quarter 2020 Financial Results on August 10, 2020

SANTA BARBARA, Calif., July  14, 2020  (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, announced today that Jeff Nugent, President and Chief Executive Officer, will participate in a virtual webinar panel discussion hosted by Maxim Group and M-Vest on Thursday July 16th, 2020.The panel discussion, Beauty after the Beast – Aesthetics during COVID-19, is part of Maxim’s COVID-19 Virtual Conference Series: Re-Engaging Medical Practices in an Era of COVID-19.

Sientra to Participate in COVID-19 Webinar Panel Hosted by Maxim Group

Sientra, Inc. (SIEN) CEO Jeffrey Nugent on Q1 2020 Results - Earnings Call Transcript

Sientra (SIEN) delivered earnings and revenue surprises of 10.20% and -9.46%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Sientra (SIEN) Reports Q1 Loss, Lags Revenue Estimates

Investors need to pay close attention to Sientra (SIEN) stock based on the movements in the options market lately.

Implied Volatility Surging for Sientra (SIEN) Stock Options

Sientra, Inc. (SIEN) CEO Jeff Nugent on Q4 2019 - Earnings Call Transcript

SANTA BARBARA, Calif., Dec.  16, 2019  (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, today announced that on December 3, 2019, the Compensation Committee of the Company’s Board of Directors approved equity award grants under the Sientra, Inc. Inducement Plan to 15 new employees.

Sientra  Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Cutera

Inmode Ltd

Aesthetics surgery is a big market, and these three companies are positioned to win from its growth.

3 Aesthetics Stocks to Watch

What should investors think of Sientra after its impressive Q3 results?

Sientra Is Finally Recovering. Is It a Buy?

Sientra's (SIEN) CEO Jeff Nugent on Q3 2019 Results - Earnings Call Transcript

Shares pop after the company reports impressive third-quarter results.

Why Sientra Is Flying High Today

Allergan

Johnson & Johnson

As breast implant-related health hazards surface, a few manufacturing companies might bear a brunt.

FDA Warns About Safety of Breast Implant: 3 Stocks at Risk (Revised)

FDA Warns About Safety of Breast Implant: 3 Stocks at Risk

SANTA BARBARA, Calif., Sept.  17, 2019  (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, today announced that on September 12, 2019, the Compensation Committee of the Company’s Board of Directors approved equity award grants under the Sientra, Inc. Inducement Plan to 13 new employees.

Sientra - Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Callon Petroleum

Galmed Pharmaceuticals

Tellurian

Viking Therapeutics

While most of Wall Street focuses on large and mega cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.

Healthy Upside Potential Seen in 5 More Stocks Trading Under $10

Encana

Evolent Health

Falcon Minerals Corp

Vivint Solar

Big Upside Potential Seen for These 5 Stocks Trading Under $10

Sientra's (SIEN) CEO Jeff Nugent on Q2 2019 Results - Earnings Call Transcript

Agile Therapeutics

CannTrust Holdings

Himax Tech

Northern Oil and Gas

5 Stocks to Buy Priced Below $10 With Monster Upside Potential

Shares of Sientra Inc (NASDAQ: SIEN) have declined about 25 percent since the company reported its first-quarter results on May 8.

Wells Fargo Upgrades Sientra After FDA, Financing Concerns Ease

Sientra, Inc. (SIEN) CEO Jeff Nugent on Q1 2019 Results - Earnings Call Transcript

The FDA approved a design change for the company's Opus breast implants.

Here's Why Sientra's Shares Got a Lift Today

Investors are worried about the aesthetics company's profitability.

News for Sientra Stock (SIEN)